Acadia Pharmaceuticals (ACAD) PT Raised to $15 at Jefferies
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.24 --0%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 13
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 13
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $15.00 (from $10.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
- CrowdStrike (CRWD) PT Raised to $235 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
